According to Adaptimmune Therapeutics's latest financial reports the company's total assets are C$0.45 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | C$0.37 B | -16.01% |
2022-12-31 | C$0.44 B | -25.41% |
2021-12-31 | C$0.59 B | 4.03% |
2020-12-31 | C$0.57 B | 142.61% |
2019-12-31 | C$0.23 B | -37.1% |
2018-12-31 | C$0.37 B | 6.65% |
2017-12-31 | C$0.35 B | 12.16% |
2016-12-31 | C$0.31 B | |
2015-06-30 | C$0.37 B | 530.21% |
2014-06-30 | C$59.21 M | 3008.93% |
2013-06-30 | C$1.9 M | -52.82% |
2012-06-30 | C$4.03 M |